Skip to content
healthcare.dev

VARIVAX

NDC 0006-4827, Varicella Virus Vaccine Live, injection, powder, lyophilized, for suspension, from Merck Sharp & Dohme LLC.

Product NDC
0006-4827
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
SUBCUTANEOUS
Product type
VACCINE
Marketing category
BLA
Application
BLA103552
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4827 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN1350 [PFU]/.5mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Chickenpox Vaccine [CS]; Herpes Zoster Vaccine [CS]; Live Attenuated Herpes Zoster Virus Vaccine [EPC]; Live Attenuated Varicella Zoster Virus Vaccine [EPC]; Vaccines, Attenuated [CS]

Package NDCNDC-11Package
0006-4827-000000648270010 VIAL, SINGLE-DOSE in 1 CARTON (0006-4827-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4827-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0006-4827 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4827 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0006-4827. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.